亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費(fèi)注冊|忘記密碼|管理入口 返回主站||保存桌面|手機(jī)瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

深圳市思科達(dá)生物技術(shù)有限公司  

專業(yè)經(jīng)營化學(xué)標(biāo)準(zhǔn)品,對照品

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:楊森
  • 電話:0755-89218244
  • 郵件:lq@szskerd.com
  • 傳真:0755-28984072
  • QQ:793285927
站內(nèi)搜索
 
榮譽(yù)資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
索拉菲尼
單價 面議對比
詢價 暫無
發(fā)貨 廣東深圳市付款后3天內(nèi)
品牌 深圳市思科達(dá)生物技術(shù)有限公司
過期 長期有效
更新 2014-12-02 13:09
 
詳細(xì)信息
 產(chǎn)品名稱:索拉菲尼 雜質(zhì) 標(biāo)準(zhǔn)品 對照品 284461-73-0

產(chǎn)品關(guān)鍵詞:索拉菲尼 雜質(zhì) 標(biāo)準(zhǔn)品 對照品 284461-73-0

索拉菲尼                                                Sorafenib                                     100mg

索拉菲尼雜質(zhì)A                                    Sorafenib Impurity A                  10mg/25mg/50mg

索拉菲尼雜質(zhì)B                                    Sorafenib Impurity B                  10mg/25mg/50mg

索拉菲尼雜質(zhì)C                                    Sorafenib Impurity C                  10mg/25mg/50mg

索拉菲尼雜質(zhì)D                                    Sorafenib Impurity D                  10mg/25mg/50mg

索拉菲尼雜質(zhì)E                                    Sorafenib Impurity E                  10mg/25mg/50mg

索拉菲尼雜質(zhì)F                                     Sorafenib Impurity F                  10mg/25mg/50mg

索拉菲尼雜質(zhì)G                                    Sorafenib Impurity G                  10mg/25mg/50mg

索拉菲尼雜質(zhì)H                                    Sorafenib Impurity H                  10mg/25mg/50mg

索拉菲尼雜質(zhì)I                                     Sorafenib Impurity I                   10mg/25mg/50mg

索拉菲尼雜質(zhì)J                                     Sorafenib Impurity J                   10mg/25mg/50mg

索拉菲尼雜質(zhì)K                                    Sorafenib Impurity K                  10mg/25mg/50mg

©2025 深圳市思科達(dá)生物技術(shù)有限公司 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:12469  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |